Park SS - Search Results

1

Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders.

Hang A, Feldman S, Amin AP, Ochoa JAR, Park SS. Hang A, et al. Among authors: park ss. Pharmaceuticals (Basel). 2023 Aug 11;16(8):1140. doi: 10.3390/ph16081140. Pharmaceuticals (Basel). 2023. PMID: 37631054 Free PMC article. Review.

2

Retinal Vessel Density in Exudative and Nonexudative Age-Related Macular Degeneration on Optical Coherence Tomography Angiography.

Lee SC, Tran S, Amin A, Morse LS, Moshiri A, Park SS, Yiu G. Lee SC, et al. Among authors: park ss. Am J Ophthalmol. 2020 Apr;212:7-16. doi: 10.1016/j.ajo.2019.11.031. Epub 2019 Dec 16. Am J Ophthalmol. 2020. PMID: 31837316 Free PMC article.

3

Factors Affecting Repeatability of Foveal Avascular Zone Measurement Using Optical Coherence Tomography Angiography in Pathologic Eyes.

Buffolino NJ, Vu AF, Amin A, De Niear M, Park SS. Buffolino NJ, et al. Among authors: park ss. Clin Ophthalmol. 2020 Apr 5;14:1025-1033. doi: 10.2147/OPTH.S247172. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32308362 Free PMC article.

4

Long-Term Retinal Vascular Changes in Age-Related Macular Degeneration Measured Using Optical Coherence Tomography Angiography.

Lee SC, Rusakevich AM, Amin A, Tran S, Emami-Naeini P, Moshiri A, Park SS, Yiu G. Lee SC, et al. Among authors: park ss. Ophthalmic Surg Lasers Imaging Retina. 2022 Oct;53(10):529-536. doi: 10.3928/23258160-20220919-01. Epub 2022 Oct 1. Ophthalmic Surg Lasers Imaging Retina. 2022. PMID: 36239679

5

Phase I/II Randomized Study of Proton Beam with Anti-Vascular Endothelial Growth Factor for Exudative Age-Related Macular Degeneration: One-Year Results.

Osmanovic S, Moisseiev E, Mishra KK, Daftari I, Moshiri A, Morse L, Park SS. Osmanovic S, et al. Among authors: park ss. Ophthalmol Retina. 2017 May-Jun;1(3):217-226. doi: 10.1016/j.oret.2016.11.003. Epub 2016 Dec 28. Ophthalmol Retina. 2017. PMID: 31047424

6

Intravitreal autologous bone marrow CD34+ cell therapy for ischemic and degenerative retinal disorders: preliminary phase 1 clinical trial findings.

Park SS, Bauer G, Abedi M, Pontow S, Panorgias A, Jonnal R, Zawadzki RJ, Werner JS, Nolta J. Park SS, et al. Invest Ophthalmol Vis Sci. 2014 Dec 9;56(1):81-9. doi: 10.1167/iovs.14-15415. Invest Ophthalmol Vis Sci. 2014. PMID: 25491299 Free PMC article. Clinical Trial.

7

Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia.

Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS. Moisseiev E, et al. Among authors: park ss. Curr Eye Res. 2017 Oct;42(10):1358-1367. doi: 10.1080/02713683.2017.1319491. Epub 2017 Jun 21. Curr Eye Res. 2017. PMID: 28636406 Free PMC article.

8

Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.

Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.

9

Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Report 18.

Scott IU, Oden NL, VanVeldhuisen PC, Ip MS, Blodi BA; SCORE2 Study Investigator Group. Scott IU, et al. JAMA Ophthalmol. 2022 May 1;140(5):458-464. doi: 10.1001/jamaophthalmol.2022.0352. JAMA Ophthalmol. 2022. PMID: 35323843 Free PMC article. Clinical Trial.

10

Real-World Experience Using Intravitreal Brolucizumab Alone or in Combination with Aflibercept in the Management of Neovascular Age-Related Macular Degeneration.

Mehta N, Fong RD, Wilson M, Moussa K, Emami-Naeini P, Moshiri A, Yiu G, Park SS. Mehta N, et al. Among authors: park ss. Clin Ophthalmol. 2023 Feb 27;17:657-665. doi: 10.2147/OPTH.S399590. eCollection 2023. Clin Ophthalmol. 2023. PMID: 36880020 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,118 results

Search Page

Filters